HIV & AIDS

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

Diseases, Conditions, Syndromes

GPS data could help map COVID-19 transmission risk

Human mobility data gathered from de-identified mobile devices could help map coronavirus (COVID-19) transmission and support contact tracing efforts, according to new research.

Addiction

One in four regional Australian teens using vapes: Study

Over a quarter of people aged 14–17 have used e-cigarettes ("vaped") and one in 10 have done so within the last 30 days, according to a new study published in the Medical Journal of Australia.

page 2 from 3